Revenue
0 USD
2026 Q3 · USD
Exact inputs and evidence
- Revenue: 0 USD Source
Annual consolidated revenue for 2025: about USD 0, using the latest reported figures. The previous period, 2024, was about USD 0.
59 USD
40972050 shares
5.16% · 2.01 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
0 USD
2025-05-01 – 2026-04-30
-4.44 million USD
2025-05-01 – 2026-04-30
-71.6 thousand USD
2025-05-01 – 2026-04-30
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-06-11.
Financial data available through: 2025-07-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 0
–
Current period
USD 0
–
0 − 0 = 0 USD
0 USD · 2023-08-01 – 2024-07-31
Inspect prior input Prior source0 USD · 2024-08-01 – 2025-07-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 178,569
–
Current period
−USD 199,269
–
-199269 − -178569 = -20700 USD
-178569 USD · 2023-08-01 – 2024-07-31
Inspect prior input Prior source-199269 USD · 2024-08-01 – 2025-07-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 101,637
–
Current period
−USD 125,181
–
-125181 − -101637 = -23544 USD
-101637 USD · 2023-08-01 – 2024-07-31
Inspect prior input Prior source-125181 USD · 2024-08-01 – 2025-07-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2016 2015-08-01 – 2016-07-31 | 121327 | Unavailable | Unavailable | Unavailable | -3743 | Unavailable | Source
|
| 2017 2016-08-01 – 2017-07-31 | 128147 | Unavailable | Unavailable | Unavailable | -32858 | Unavailable | Source
|
| 2018 2017-08-01 – 2018-07-31 | 93550 | Unavailable | Unavailable | Unavailable | -28167 | -14644 Derived | Source
|
| 2024 2023-08-01 – 2024-07-31 | 0 | 163593 Derived | -163593 | 14976 Derived | -178569 | Unavailable | Source
|
| 2025 2024-08-01 – 2025-07-31 | 0 | 180537 Derived | -180537 | 18732 Derived | -199269 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Revenue | 121327 |
|
| 2017 | Revenue | 128147 |
|
| 2018 | Revenue | 93550 |
|
| 2024 | Revenue | 0 |
|
| 2025 | Revenue | 0 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Year over year | No prior comparable period |
|
| 2017 | Year over year | 5.6% |
|
| 2018 | Year over year | -27% |
|
| 2024 | Year over year | No prior comparable period |
|
| 2025 | Year over year | No prior comparable period |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016-07-31 | Operating margin | Not reported |
|
| 2017-07-31 | Operating margin | Not reported |
|
| 2018-07-31 | Operating margin | Not reported |
|
| 2024 | Operating margin | Not reported |
|
| 2025 | Operating margin | Not reported |
|
| 2016 | Net margin | -3.1% |
|
| 2017 | Net margin | -25.6% |
|
| 2018 | Net margin | -30.1% |
|
| 2024 | Net margin | Not reported |
|
| 2025 | Net margin | Not reported |
|
| 2016 | Free cash flow margin | Not reported |
|
| 2017 | Free cash flow margin | Not reported |
|
| 2018 | Free cash flow margin | -15.7% |
|
| 2024 | Free cash flow margin | Not reported |
|
| 2025 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Operating cash flow | -3823 |
|
| 2017 | Operating cash flow | -38077 |
|
| 2018 | Operating cash flow | -2744 |
|
| 2024 | Operating cash flow | -101637 |
|
| 2025 | Operating cash flow | -125181 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Free cash flow | Unavailable |
|
| 2017 | Free cash flow | Unavailable |
|
| 2018 | Free cash flow | -14644 |
|
| 2024 | Free cash flow | Unavailable |
|
| 2025 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016-07-31 | Liabilities / assets | Not reported |
|
| 2017-07-31 | Liabilities / assets | Not reported |
|
| 2018-07-31 | Liabilities / assets | Not reported |
|
| 2024 | Liabilities / assets | 2,933% |
|
| 2025 | Liabilities / assets | 75,565.2% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Current assets / current liabilities | 0.18× |
|
| 2017 | Current assets / current liabilities | 74.48× |
|
| 2018-07-31 | Current assets / current liabilities | Not reported |
|
| 2024 | Current assets / current liabilities | 0.03× |
|
| 2025 | Current assets / current liabilities | 0× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2016 2015-08-01 – 2016-07-31 | −USD 3,743 Exact valueExact value: -3743 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3,823 Exact valueExact value: -3823 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2017 2016-08-01 – 2017-07-31 | −USD 32,858 Exact valueExact value: -32858 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 38,077 Exact valueExact value: -38077 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2018 2017-08-01 – 2018-07-31 | −USD 28,167 Exact valueExact value: -28167 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2,744 Exact valueExact value: -2744 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 11,900 Exact valueExact value: 11900 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 14,644 Calculation and evidence-2744 − 11900 USD Exact free cash flow: -14644 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2023-08-01 – 2024-07-31 | −USD 178,569 Exact valueExact value: -178569 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 101,637 Exact valueExact value: -101637 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2024-08-01 – 2025-07-31 | −USD 199,269 Exact valueExact value: -199269 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 125,181 Exact valueExact value: -125181 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
20 filings · 871 latest values · 871 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001663038, 1663038, QGAI, edgar:1663038
Also known as QUANTUMZYME CORP, QUANTUMZYME CORP., Quantum Genesis AI Corp., Quantumzyme Corp., RELIANT SERVICE INC, Reliant Service Inc